# Annovis Bio, Inc.: Form 8-K, filed Jul 10, 2026

- Company: [Annovis Bio, Inc.](/companies/anvs.md) (CIK 1477845)
- Form: 8-K
- Filed: 2026-07-10
- Accepted by EDGAR: Jul 9, 2026, 21:06 ET
- Period: 2026-07-07
- Accession: 0001104659-26-082341
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1477845/000110465926082341/tm2620172d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1477845/000110465926082341/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1477845/000110465926082341/tm2620172d1_8k.htm

Filed Jul 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-082341. Last ingested by Listed: Nov 6, 2026, 17:28 ET. No prices; not investment advice.